Johnson Financial Group, Inc. Biogen Inc. Transaction History

Johnson Financial Group, Inc.

$2.06 Billion
Q2 2024

A detailed history of Johnson Financial Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 39 shares of BIIB stock, worth $7,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 39 -0.0%

Holding current value

$7,559

Previous $8,000 12.5%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $9,752 - $12,314	-46 Reduced 54.12%	39 $8,000
Q4 2023 Feb 09, 2024	BUY	$222.59 - $267.94 $6,232 - $7,502	28 Added 49.12%	85 $21,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $14,438 - $16,295	57 New	57 $14,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $19,257 - $24,748	-86 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $233,466 - $304,466	-825 Reduced 90.56%	86 $24,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $44,548 - $71,330	172 Added 23.27%	911 $315,000
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $54,420 - $63,757	224 Added 43.5%	739 $207,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $75,130 - $113,090	-318 Reduced 38.18%	515 $126,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $16,945 - $19,565	64 Added 8.32%	833 $236,000
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $10,346 - $13,702	40 Added 5.49%	769 $206,000
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $6,452 - $8,184	24 Added 3.4%	729 $231,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $44,672 - $61,726	-203 Reduced 22.36%	705 $209,000
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $22,831 - $25,607	105 Added 13.08%	908 $211,000
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $11,183 - $12,327	51 Added 6.78%	803 $188,000
Q1 2019 May 13, 2019	BUY	$216.71 - $338.96 $13,869 - $21,693	64 Added 9.3%	752 $178,000
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $114,185 - $144,627	410 Added 147.48%	688 $207,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $4,989 - $6,525	17 Added 6.51%	278 $98,000
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $11,588 - $13,810	-45 Reduced 14.71%	261 $76,000
Q1 2018 May 07, 2018	SELL	$260.13 - $367.91 $399,039 - $564,373	-1,534 Reduced 83.37%	306 $84,000
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $35,378 - $39,626	-115 Reduced 5.88%	1,840 $586,000
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $549,648 - $644,543	1,955	1,955 $612,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.

Account

Johnson Financial Group, Inc. Biogen Inc. Transaction History